Brainlab Quentry First Online Medical Platform to Receive EuroPriSe European Data Privacy Seal

Brainlab AGBrainlab, a global leader in medical technology, today announced that it has received the EuroPriSe European Data Privacy Seal for Quentry® by Brainlab. The seal certifies that Quentry is compliant with data protection directives implemented by all European states.

Quentry enables medical professionals to share images, display the images in a web-based viewer and add comments such as medical opinions. Quentry supports clinicians throughout the referral, review, planning and treatment workflow, supporting patient data management and collaboration. Quentry is the first cloud-based medical service to receive certification from EuroPriSe.

Addressing regulations on privacy and data security for all European states, EuroPriSe certification required a rigorous, two-year evaluation process. Quentry underwent this robust audit, which improved upon and validated the platform’s technical and organizational measures and multilayered encryption technology embedded in the architecture.

Quentry employs advanced encryption and access control technologies that approximate the level of a true end-to-end encryption to the greatest extent possible. This safeguards that all sensitive medical information is protected. Data uploaded and stored on Quentry can only be accessed and viewed by authorized individuals.

"With an increasing number of worldwide data security breaches, protecting patient and user data is vital to any cloud-based medical platform," said Rainer Birkenbach, Executive Vice President. "Brainlab developers built a multi-layered encryption system, which protects all patient data against unjustified inspection - even service providers and administrators are not able to individually decrypt data. Our goal was to go above and beyond the most stringent requirements for high-level data protection that customers and government regulators demand with Quentry. We’re pleased to see our efforts rewarded by EuroPriSe."

The responsibility for the lawful processing of patient data lies with the users of the service. They are advised by Brainlab that the legitimate use of Quentry requires the collection of patients' informed consent and release from medical confidentiality and that they are obliged to verify the identity of other users in a reliable way prior to sharing medical information with them.

"Brainlab expended a great deal of effort in order to ensure the confidentiality of sensitive data," says Sebastian Meissner, Head of the EuroPriSe Certification Authority. Meissner said positive aspects of Quentry include, "comprehensive privacy hints provided to users and the ability to de-identify meta data about patients."

The EuroPriSe seal is valid for two years, and will continuously be re-evaluated when new features and functionalities are added to Quentry.

About Brainlab
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 18 offices worldwide, including 320 Research & Development engineers, who form a crucial part of the product development team.

About EuroPriSe
EuroPriSe started as an EU-funded project aimed at establishing a trans-European privacy seal. Today, EuroPriSe offers certifications for IT products, IT-based services and websites throughout the EU. A unique certification, the EuroPriSe seal assures users that their personal data are handled in accordance with European data protection laws. As the only EU-wide, independent privacy seal, EuroPriSe enables enterprises to demonstrate their compliance with European laws and regulations. EuroPriSe certifications have been awarded to businesses of all sizes, including small and medium-sized companies as well as multinational organizations such as Microsoft and SAP.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...